Has Erlinda Gordon received payments from drug or device companies?

Yes. Drug and device makers reported $21,494 in general payments to Erlinda Gordon across 470 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erlinda Gordon did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erlinda Gordon come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erlinda Gordon

Pediatric Hematology-Oncology · Monterey, CANPI 1922191717

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Aadi Bioscience, Inc. at 49.4% of the total. Reporting peaked in 2023 at $10,667 and has fallen 78.1% since, to $2,340 in 2025.

$21,494in general payments, 2019–2025

Across 470 payments — averaging $45.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aadi Bioscience, Inc.$11K
Merck$831
Daiichi Sankyo Inc.$794
Bayer$649
Incyte Corporation$616
Novartis$556
plus $7K from 54 others

$1,285,736in research payments, 2019–2025

Across 17 payments — averaging $75,632 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Aadi Bioscience, Inc.$818K
Jazz Pharmaceuticals Inc.$405K
E.r. Squibb & Sons, L.L.C.$62K
Pfizer$940

What the payments were for

Consulting fees$8,48839%
Speaking & faculty fees$1,5007%
Food & beverage$11,40653%
Education$1000%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aadi Bioscience, Inc.	19	$10,628
Merck	33	$831
Daiichi Sankyo Inc.	32	$794
Bayer	32	$649
Incyte Corporation	25	$616
Novartis	26	$556
Coherus Oncology, Inc.	37	$544
AstraZeneca(2 entities)	17	$514
Ipsen Biopharmaceuticals, Inc	15	$441
Lilly USA, LLC	17	$410
Seagen Inc.	18	$407
E.r. Squibb & Sons, L.L.C.	10	$400
Taiho Oncology, Inc.	15	$318
Pfizer	9	$244
Karyopharm Therapeutics Inc.	8	$241
Takeda Pharmaceuticals U.S.A., Inc.	9	$240
Amgen	9	$213
Gilead(2 entities)	8	$201
Jazz Pharmaceuticals Inc.	4	$197
Eisai Inc.	8	$172
Dendreon Pharmaceuticals LLC	6	$159
Sanofi	6	$154
Kyowa Kirin, Inc.	6	$142
Genmab U.S., Inc.	5	$140
Blueprint Medicines Corporation	6	$139
GSK	5	$120
Agios Pharmaceuticals, Inc.	5	$119
Tersera Therapeutics LLC	4	$116
Johnson & Johnson	4	$99
Springworks Therapeutics, Inc.	4	$96
Genentech USA, Inc.	3	$91
Tolmar Pharmaceuticals, Inc.	4	$89
Puma Biotechnology, Inc.	2	$87
Bristol Myers Squibb	4	$84
Deciphera Pharmaceuticals Inc.	4	$83
Spectrum Pharmaceuticals Inc.	3	$78
Tesaro, Inc.	2	$72
Sobi, Inc	3	$63
Caris MPI, Inc.	1	$60
Morphosys, US Inc.	3	$59
Heron Therapeutics, Inc.	3	$58
Array Biopharma Inc	2	$55
Mylan Institutional Inc.	3	$55
GE HealthCare	2	$50
AbbVie	2	$37
Helsinn Therapeutics (U.S.), Inc.	2	$36
Acrotech Biopharma Inc.	1	$35
Beigene USA, Inc.	1	$34
Janssen Scientific Affairs, LLC	1	$32
Boehringer Ingelheim	1	$30
EMD Serono, Inc.	1	$28
Blue Earth Diagnostics	1	$27
Progenics Pharmaceuticals, Inc.	1	$27
Stemline Therapeutics Inc.	1	$25
Iovance Biotherapeutics, Inc.	2	$25
Global Blood Therapeutics, Inc.	1	$24
Tolmar, Inc.	1	$24
CTI Biopharma Corp.	1	$24
Teva Pharmaceuticals USA, Inc.	1	$23
Catalyst Pharmaceuticals, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FYARRO$10,193
Enhertu$250
OPDIVO$241
TAZVERIK$126

How this compares

$21,494 in reported general payments places this provider in the 85th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California →

Other pediatric hematology-oncology in Monterey

Philip PizzoPalo Alto$2.6M
Vinod BalasaMadera$508K
Akshat JainRedlands$447K
Noah FedermanLos Angeles$399K
Vanessa Salinas-LunaOrange$344K
Daniel KraftStanford$294K
Arash MahajerinOrange$249K
Elysia AlvarezPalo Alto$200K
Christopher DvorakPalo Alto$144K
Jan van TornoutLos Angeles$137K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →